Suppr超能文献

达英-35与苍附导痰丸联合使用可有效改善多囊卵巢综合征(PCOS)患者的炎症反应、应激状态和激素水平,显著提高临床治疗效果。

Combination of Diane-35 and Cangfu Daotan Wan Effectively Ameliorates Inflammatory Response, Stress State, and Hormone Levels in Patients with Polycystic Ovary Syndrome (PCOS), Leading to Significant Improvement in Clinical Treatment Outcomes.

作者信息

Chen Li, Fang Cai-Ping, Chen Yan, Gu Wei-Hua, Wang Sai-Li, Niu Ning, Zhang Qin-Hua

机构信息

Department of Gynecology, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, People's Republic of China.

Department of Gynecology, Shanghai Shuguang Hospital, Shanghai, People's Republic of China.

出版信息

Int J Womens Health. 2025 Jul 29;17:2353-2364. doi: 10.2147/IJWH.S526092. eCollection 2025.

Abstract

OBJECTIVE

To assess the impact of combining Diane-35 with Cangfu Daotan Wan on inflammatory response, stress response, and hormone levels in patients with polycystic ovary syndrome (PCOS), and to offer insights for clinical management.

METHODS

A retrospective analysis was conducted from January 2022 to March 2024, encompassing PCOS patients treated at our hospital who fulfilled the inclusion criteria. Patients were categorized into two groups: the study group receiving Diane-35 plus Cangfu Daotan Wan, and the control group receiving Diane-35 alone. Comparisons were made between the two groups regarding inflammatory markers, stress response indicators, hormone levels, and overall treatment efficacy.

RESULTS

Post-treatment, the study group exhibited a lower incidence of polycystic ovarian changes and a higher overall efficacy rate compared to the control group (P<0.05). Inflammatory factors IL-6, TNF-α, and MCP-1 were significantly reduced in the study group versus the control group (P<0.05). Oxidative stress markers SOD and GSH were significantly elevated, while GSS was significantly decreased in the study group compared to the control group (P<0.05). No significant differences were observed in FSH, LH, LH/FSH ratio, or testosterone levels between the two groups (P>0.05). The BMI index was significantly lower in the study group than in the control group (P<0.05). Additionally, traditional Chinese medicine symptom scores were significantly reduced in the study group compared to the control group (P<0.05).

CONCLUSION

The combination of Diane-35 and Cangfu Daotan Wan effectively ameliorates inflammatory response and stress state, modulates hormone levels, and enhances clinical treatment outcomes in PCOS patients. This combined therapy is both safe and efficacious, warranting further application in clinical practice.

摘要

目的

评估达英-35联合苍附导痰丸对多囊卵巢综合征(PCOS)患者炎症反应、应激反应及激素水平的影响,为临床治疗提供参考。

方法

对2022年1月至2024年3月在我院接受治疗且符合纳入标准的PCOS患者进行回顾性分析。将患者分为两组:研究组接受达英-35加苍附导痰丸治疗,对照组仅接受达英-35治疗。比较两组患者的炎症指标、应激反应指标、激素水平及总体治疗效果。

结果

治疗后,研究组多囊卵巢改变发生率低于对照组,总体有效率高于对照组(P<0.05)。研究组炎症因子IL-6、TNF-α和MCP-1水平较对照组显著降低(P<0.05)。与对照组相比,研究组氧化应激指标SOD和GSH显著升高,GSS显著降低(P<0.05)。两组FSH、LH、LH/FSH比值及睾酮水平比较,差异无统计学意义(P>0.05)。研究组BMI指数显著低于对照组(P<0.05)。此外,研究组中医症状评分较对照组显著降低(P<0.05)。

结论

达英-35联合苍附导痰丸可有效改善PCOS患者的炎症反应和应激状态,调节激素水平,提高临床治疗效果。该联合疗法安全有效,值得在临床实践中进一步应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5a6/12317708/45c753852162/IJWH-17-2353-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验